NCT06613763View on ClinicalTrials.gov

A Study of RAY1225 in Participants With Impaired Kidney Function

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 11, 2024

Primary Completion Date

January 10, 2025

Study Completion Date

January 20, 2025

Conditions
Kidney Impairment
Interventions
DRUG

RAY1225

Administered SC

Trial Locations (1)

Unknown

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors
lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY

NCT06613763 - A Study of RAY1225 in Participants With Impaired Kidney Function | Biotech Hunter | Biotech Hunter